We are live on ! Find out more
ANAC

ANACOR PHARMACEUTICALS INC COM
ANAC

Delisted

ANAC was delisted on the 23rd of June, 2016.

Back to rankings

87 hedge funds and large institutions have $535M invested in ANACOR PHARMACEUTICALS INC COM in 2013 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 23 increasing their positions, 32 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

75% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 12

66% more capital invested

Capital invested by funds: $321M → $535M (+$213M)

25% more call options, than puts

Call options by funds: $362K | Put options by funds: $289K

12% more funds holding

Funds holding: 78 → 87 (+9)

28% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 32

Holders
87
Holders Change
+9
Holders Change %
+11.54%
% of All Funds
2.53%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.15%
New
21
Increased
23
Reduced
32
Closed
12
Calls
$362K
Puts
$289K
Net Calls
+$73K
Net Calls Change
-$411K

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$22.5M
2
PHS
PFM Health Sciences
California
+$14.6M
3
CCM
Consonance Capital Management
New York
+$8.75M
4
State Street
State Street
Massachusetts
+$6.84M
5
Jennison Associates
Jennison Associates
New York
+$5.31M

Top Sellers

Rank Fund Capital Flow
1
RCP
Rho Capital Partners
New York
-$21.5M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$15M
3
PA
Perceptive Advisors
New York
-$6.73M
4
LOAMU
Lombard Odier Asset Management (USA)
New York
-$3.47M
5
BC
Broadfin Capital
New York
-$3.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
26
Bogle Investment Management
Massachusetts
$3.03M +$2.5M +180,437 New
U
27
UBS
Switzerland
$2.96M +$549K +39,648 +29%
Axa
28
Axa
France
$2.82M +$2.33M +168,172 New
Deutsche Bank
29
Deutsche Bank
Germany
$2.69M -$427K -30,836 -16%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$2.68M +$372K +26,918 +20%
Invesco
31
Invesco
Georgia
$2.6M +$244K +17,627 +13%
MSA
32
Mason Street Advisors
Wisconsin
$2.26M – – –
RFC
33
Russell Frank Company
Washington
$2.09M -$626K -45,232 -29%
BCM
34
Bridgeway Capital Management
Texas
$1.98M -$1.18M -85,300 -42%
Renaissance Technologies
35
Renaissance Technologies
New York
$1.77M +$1.46M +105,800 New
Fidelity Investments
36
Fidelity Investments
Massachusetts
$1.68M +$1.38M +100,000 New
TCIM
37
TIAA CREF Investment Management
New York
$1.63M -$40.8K -2,950 -3%
CS
38
Credit Suisse
Switzerland
$1.52M +$50.5K +3,649 +4%
USAA
39
United Services Automobile Association
Texas
$1.4M -$473K -34,170 -29%
Ameriprise
40
Ameriprise
Minnesota
$1.37M -$221K -15,989 -16%
B
41
Baird
Wisconsin
$1.3M +$1.07M +77,411 New
Dimensional Fund Advisors
42
Dimensional Fund Advisors
Texas
$1.22M +$1.01M +72,690 New
BIM
43
BlackRock Investment Management
Delaware
$1.17M -$32.3K -2,332 -3%
WMSA
44
Weiss Multi-Strategy Advisers
New York
$1.01M -$277K -20,000 -25%
ACM
45
Atika Capital Management
New York
$956K +$789K +57,000 New
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$869K +$18.4K +1,328 +3%
AQR Capital Management
47
AQR Capital Management
Connecticut
$824K +$680K +49,130 New
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$769K +$2.77K +200 +0.4%
DC
49
Deere & Company
Illinois
$763K -$121K -8,722 -16%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$621K -$15.2K -1,100 -3%
1
2
3 4

ANAC Hedge Fund Activity: Q4 2013 in Review

87 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q4 2013, worth a combined $535M — up 66% from $321M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new ANAC positions and 12 closed out — a net gain of 9 holders — while 23 added to existing stakes and 32 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $22.5M. The largest seller was Rho Capital Partners, cutting an estimated $21.5M.

  • 87 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q4 2013, up from 78 in Q3 2013.
  • Funds reported $535M of ANACOR PHARMACEUTICALS INC COM stock for Q4 2013, up 66% quarter-over-quarter.
  • 21 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q4 2013 and 12 closed out, a net change of +9 holders.
  • The largest ANACOR PHARMACEUTICALS INC COM buyer in Q4 2013 was Baker Bros. Advisors, an estimated $22.5M added.
  • The largest ANACOR PHARMACEUTICALS INC COM seller in Q4 2013 was Rho Capital Partners, an estimated $21.5M sold.

Based on aggregated 13F filings for Q4 2013.